Thus, considering the fail safe system of future clinical trial, we should establish the selective ablation of the grafted-cell using such as the herpes simplex thymidine kinase (HSV-tk) and “suicide” gene system [43], [44], if tumor formation occurred after human iPS-NS/PC transplantation. This evidence concerns the gene TKT and neoplasm.